FTC Suggests FDA Scrap Current Homeopathic Regulatory Framework
This article was originally published in The Pink Sheet Daily
Executive Summary
In comments on FDA’s homeopathic product regulation, FTC puts in writing what its officials have said about conflicts between its policy for regulating ad claims and FDA’s oversight of homeopathics manufacturing and marketing.